Dr. Tianhong Li
Claim this profileUniversity of California Davis Comprehensive Cancer Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
16 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage I
2Non-Small Cell Lung Cancer
Stage IV
Stage III
RET positive
Affiliated Hospitals
Clinical Trials Tianhong Li is currently running
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
ONC-841
for Cancer
This is a Phase I open label, dose-escalation study of intravenous (IV) infusion of ONC-841 as a single agent in patients with advanced/metastatic solid tumors. The study will evaluate seven dose levels of ONC-841 starting from 0.03 mg/kg to 30 mg/kg.
Recruiting1 award Phase 1
More about Tianhong Li
Clinical Trial Related2 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Tianhong Li has experience with
- Docetaxel
- ONC-392
- Pembrolizumab
- Atezolizumab
- ONC-841
- Sargramostim
Breakdown of trials Tianhong Li has run
Lung Cancer
Non-Small Cell Lung Cancer
Solid Tumors
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tianhong Li specialize in?
Tianhong Li focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Tianhong Li currently recruiting for clinical trials?
Yes, Tianhong Li is currently recruiting for 5 clinical trials in Sacramento California. If you're interested in participating, you should apply.
Are there any treatments that Tianhong Li has studied deeply?
Yes, Tianhong Li has studied treatments such as Docetaxel, ONC-392, Pembrolizumab.
What is the best way to schedule an appointment with Tianhong Li?
Apply for one of the trials that Tianhong Li is conducting.
What is the office address of Tianhong Li?
The office of Tianhong Li is located at: University of California Davis Comprehensive Cancer Center, Sacramento, California 95817 United States. This is the address for their practice at the University of California Davis Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.